Photo from U.S. FDA
Jun 28, 2024, 02:39
FDA guidance provides new details on diversity action plans required for certain studies
U.S. FDA shared a post on X:
“Today, Food and Drug Administration issued a draft guidance to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies.”
Devika Das, Medical Director at Parexel shared on X adding:
“Let us design and run trials that are equitable towards all of the population they are meant to serve. FDA issued guidance from today.”
Source: U.S. FDA/X and Devika Das/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32